Author | Bernd Kasper, MD, PhD | OncLive

Author | Bernd Kasper, MD, PhD

Articles

Dr. Kasper on Future Treatment Approaches in Sarcoma

May 17, 2017

Video

Bernd Kasper, MD, PhD, professor, Universitätsmedizin Mannheim, Mannheim, discusses future treatment approaches in the field of sarcoma and the potential role of imatinib (Gleevac).

Dr. Kasper on Imatinib Versus Sorafenib in Sarcoma

March 18, 2017

Video

Bernd Kasper, MD, PhD, professor, Universitätsmedizin Mannheim, Mannheim, discusses imatinib (Gleevac) versus sorafenib (Nexavar) as treatments for patients with sarcoma.

Dr. Kasper on Imatinib in Resistant Progressive Desmoid Tumors

January 20, 2017

Video

Bernd Kasper, MD, PhD, professor, Universitätsmedizin Mannheim, Mannheim, discusses results of a phase II study exploring the efficacy of imatinib (Gleevac) in patients with racist progressive demoed tumors.

x